regulatory approval
NMPA Approves Eli Lilly, Innovent's Immunotherapy Tyvyt for EGFR-Mutant NSCLC
The approval marks the first PD-1 inhibitor to be approved for patients with EGFR-mutant NSCLC.
Amoy Diagnostics PLC Panel Gets Approval in Japan as CDx for Retevmo in Non-Small Cell Lung Cancer
Oncologists in Japan can now use the AmoyDx Pan Lung Cancer PCR Panel to identify patients with RET fusions that make them eligible for treatment with the Eli Lilly drug.
Prenetics' ACT Genomics Profiling Test for Solid Tumors Receives FDA Clearance
The regulatory clearance of ACTOnco comes on the heels of Prenetics' acquisition of a majority stake of ACT Genomics last month.
FDA Approves Foundation Medicine Blood Test as CDx for Rozlytrek
FoundationOne Liquid CDx, a liquid biopsy test, is the only blood-based CDx approved for the targeted cancer therapy.
Novartis' Pluvicto Approved in Europe for PSMA-Positive Castration-Resistant Prostate Cancer
The European Commission approved the radioligand treatment in combination with androgen deprivation therapy based on results of the VISION trial.